Permanent congenital hypothyroidism with blood spot thyroid stimulating hormone <10 mU/L.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27016213.
- Also identified by DOI 10.1136/archdischild-2015-309564.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The UK recommended lower threshold for neonatal blood spot thyroid stimulating hormone (TSH) screening for congenital hypothyroidism (CHT) is 10.0 mU/L. Some laboratories use lower thresholds. This will lead to referral of mildly or unaffected infants but some will require thyroxine therapy. Laboratory referrals with a first or repeat capillary TSH between 8.0 and <10.0 mU/L were identified (January 2004 to March 2014). The outcome of these cases was examined. 26 infants had one or more blood spot TSH values between 8.0 and 9.99 mU/L; 65% had transient elevated neonatal TSH while one is awaiting diagnostic challenge. The remaining eight (31%) have permanent CHT; three with dyshormonogenesis, two with thyroid ectopia and the others met the criteria for definite CHT. Two out of three with dyshormonogenesis presented with decompensated hypothyroidism. Infants with permanent and occasionally severe CHT may have a screening TSH below the UK recommended lower cut-off.
Medical subject headings
- Congenital Hypothyroidism
- Congenital Hypothyroidism/diagnosis
- Female
- Humans
- Infant
- Infant, Newborn
- Male
- Neonatal Screening
- Neonatal Screening/methods
- Reference Values
- Referral and Consultation
- Thyrotropin
- Thyrotropin/blood
- United Kingdom